Hair Loss. Nonscarring hair loss, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The patients head will receive 2 cc of conditioning medium 2 times with an interval of 60 days. Intervention 2: Control group: the position of the patients head wil
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
25 Years to 45 Years
Inclusion criteria
Inclusion criteria: Patients with male androgenetic alopecia grade 3-5 Age between 25 and 45 years
Exclusion criteria
Exclusion criteria: Presence of evidence of sepsis immunosuppression and cancer Use of oral drug treatment for androgenic hair loss (such as finasteride, dutasteride or any other anti-androgen drug) in 12 months the past Use of local drug treatment of androgenic hair loss (such as minoxidil, prostaglandin analogues, retinoids or Corticosteroids) in the last 12 months Discovering another cause for the patient's hair loss Non-cooperation of the patient until the end of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of hair loss. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Trichoscan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects (pain, burning, inflammation). Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.;Effectiveness (increasing the number of hair, increasing the thickness). Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed